Tesaro
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.
6
Funding Rounds
$457.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo**** Mo**** | - | - | - |
| Ma** Ly*** He**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo**** Mo**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Tesaro has raised a total of $356m in funding over 6 rounds.
Key Insights:
- Tesaro Venture round, April 18, 2016: $50m
- Tesaro Venture round, March 10, 2016: $155m
- Tesaro Venture round, March 6, 2013: $91m
- Tesaro Series A round, May 28, 2010: $60m
- Tesaro Series B round June 2011: $101m
Tesaro Venture round, April 18, 2016
$50m
Tesaro Venture round, March 10, 2016
$155m
Tesaro Venture round, March 6, 2013
$91m
Tesaro Series A round, May 28, 2010
$60m
Tesaro Series B round June 2011
$101m
Industries
Tesaro is active in the following industries: